Work

Safety and Response After 2 Cycles of Brentuximab Vedotin Substituting Vincristine in the Oepa/copdac Regimen for High Risk Pediatric Hodgkin Lymphoma (hl)

FWCI:
Cites:
Cited by:
Related to: 10